Rofecoxib (Vioxx) voluntarily withdrawn from market
AUTOR(ES)
Sibbald, Barbara
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=526313Documentos Relacionados
- Lawsuits mount in wake of rofecoxib (Vioxx) withdrawal
- What's all the fuss? Safety concerns about COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex)
- Why is Exubera being withdrawn?
- Nefazodone (Serzone) withdrawn because of hepatotoxicity
- Lessons from the withdrawal of rofecoxib: Observational studies should not be forgotten